Loading organizations...
Formation Bio is a New York-based biotechnology company that develops an AI-native platform designed to accelerate pharmaceutical development and optimize clinical trials. The organization integrates complex biomedical data to guide asset selection, streamline drug execution processes, and address traditional bottlenecks in clinical development. By operating as a technology-enabled pharmaceutical pipeline, the enterprise focuses on bringing new therapeutic treatments to patients with greater efficiency. The company recently secured a $372 million Series D funding round, bringing its total valuation to over $1 billion. This financing effort was supported by prominent lead investors including Andreessen Horowitz, Sanofi, and Sequoia Capital. Originally established under the name TrialSpark and supported by an executive team that includes Chief Technology Officer Dan Neil and Chief Business Officer David Steinberg, Formation Bio was founded in 2014 by Ben Liu and Linhao Zhang.
Formation has raised $5.0M across 2 funding rounds.
Formation has raised $5.0M in total across 2 funding rounds.
Formation is a technology company focused on transforming and modernizing workspaces through advanced IT solutions. It primarily serves internal IT teams and businesses by delivering cloud-based migrations, enhanced cybersecurity, integrated voice, and customer experience (CX) solutions. Formation aims to solve the problem of outdated and inflexible workplace technology, enabling clients to save time, reduce costs, and improve operational efficiency. The company has shown steady growth by evolving its offerings from cloud adoption to future-proof workspace technologies, including AI and hybrid working solutions[1][2].
Formation Tech was founded in 2015 by Dan Cholerton and Mark Tyers with the mission to modernize workspaces long held back by legacy technology and inflexible providers. The idea emerged from recognizing the need for agile, cloud-based solutions to replace aging IT infrastructure. Early traction accelerated during the Covid-19 pandemic (2016–2022), when demand for cloud migrations and remote work technologies surged. Since 2023, Formation has focused on building dynamic, secure, and integrated workspace solutions designed for the future of work, including sustainability and AI-driven enhancements[1][3].
Formation rides the wave of digital transformation and cloud adoption accelerated by global shifts such as the pandemic and hybrid work models. The timing is critical as businesses increasingly demand secure, agile, and integrated IT environments. Market forces favor companies that can deliver seamless cloud migrations, robust cybersecurity, and unified communications. Formation influences the ecosystem by enabling IT teams to modernize infrastructure efficiently, supporting broader trends in workplace digitization and AI integration[1].
Looking ahead, Formation is positioned to deepen its impact by expanding AI-driven workspace solutions, enhancing sustainability efforts, and adapting to the evolving needs of hybrid and remote workforces. Trends in AI automation, cybersecurity, and flexible work environments will shape its journey. Its influence is likely to grow as organizations seek partners that combine technical expertise with a human-led approach to technology transformation, ensuring workspaces remain resilient and future-proof[1].
---
This summary focuses on Formation Tech, the UK-based technology company specializing in workspace modernization. Note that other companies named Formation exist in different sectors (e.g., Formation Bio in pharma AI, Formation interview prep platform), but this response is tailored to the technology company described in the search results.
Formation has raised $5.0M across 2 funding rounds. Most recently, it raised $4.0M Seed in April 2021.
Formation has raised $5.0M in total across 2 funding rounds.
Formation's investors include Connie Chan, Afore Capital, Andreessen Horowitz, Awesome People Ventures, Basecamp Fund, Browder Capital, Cedar Capital Group, Charge Ventures, Convective Capital, Curie.Bio, Designer Fund, Founder Collective.
